An MDM2 degrader for treatment of acute leukemias
Bridget K. Marcellino, Xiaobao Yang, H. Ümit Kanıskan, Claudia Brady, He Chen, Karie Chen, Xing Qiu, Cara Clementelli, Lauren Herschbein, Zhijun Li, Sebastian Elghaity-Beckley, Joann Arandela, Brianna Kelly, Ronald Hoffman, Jing Liu, Yue Xiong, Jian Jin, Alan H. Shih
Topics & Concepts
Cancer researchMdm2VenetoclaxMyeloid leukemiaLeukemiaCytarabinePumaApoptosisBiologyMedicineChemistryImmunologyChronic lymphocytic leukemiaBiochemistryProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysHistone Deacetylase Inhibitors Research